Breaking Bipolar Barriers: Iloperidone's remarkable impact on mania
Unveiling a Promising Treatment Option for Bipolar Disorder
Topline:
A groundbreaking phase 3 study reveals that Iloperidone initially recognized for treating schizophrenia, demonstrates significant efficacy in alleviating bipolar mania symptoms. Patients experienced remarkable improvements in as little as 14 days, presenting a potential game-changer for bipolar disorder treatment.
Study Details:
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.